Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Slowing Down Stock
1050.4000 9.40 (0.90%)
NSE Aug 22, 2025 15:31 PM
Volume: 1.9M
 

logo
Aurobindo Pharma Ltd.
13 Nov 2018
1050.40
0.90%
buy
Results Update: Aurobindo Pharma Ltd.
by HDFC Securities
HDFC Securities
Aurobindo Pharma Ltd Q2FY19 results Comment Revenue grew by 11.61% to Rs. 4667.12 Cr in Q2FY19 when compared to the previous quarter. Also, it increased by 7.19% when compared with Q2FY18.
 
Aurobindo Pharma Ltd. has an average target of 1403.50 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended
Five Interesting Stocks Today - August 22, 2025
The Baseline | 22 Aug 2025, 05:05PM
Market closes lower, PMO reviews DoT's proposal to cut Vodafone Idea's AGR dues
Trendlyne Marketwatch | 22 Aug 2025, 03:58PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020